Next-Generation Sequencing
FDA Approves Foundation Medicine's Liquid Biopsy Test as CDx for Novartis' Tabrecta in NSCLC
The blood-based test is the second Foundation Medicine assay approved to ID patients eligible for the drug due to mutations leading to MET exon 14 skipping.
Genetron Health Receives CE Mark for Lung Cancer Sequencing Assay
The company has been commercializing the assay in China but believes that its technology will also be attractive to labs outside the country looking to bring NGS testing in house.
ACT Genomics Acquires MC Diagnostics
MC Diagnostics provides automated multiplex molecular assays and has a low-density array platform offering HLA typing and blood group diagnostics.
Genomic Testing Cooperative's Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage
The next-generation sequencing-based tests can be performed on small samples, including needle aspiration samples, and use artificial intelligence software.
Lucence Presents New Data on Liquid Biopsy for Late-Stage Cancer Monitoring, Treatment Guidance
Premium
The firm shared validation data at ASCO on its LiquidHallmark assay to help guide detection and treatment decisions for late-stage cancers.